Zheng Quan Shi Bao·2025-09-07 15:10Core Viewpoint - Sunflower is planning to acquire controlling stakes in Xi Pu Materials and 40% of Bei De Pharmaceutical through share issuance and/or cash payment, with the transaction expected to constitute a major asset restructuring [2][5] Group 1: Transaction Details - The acquisition involves Xi Pu Materials Technology Co., Ltd. and Zhejiang Bei De Pharmaceutical Co., Ltd. [2] - The valuation of both companies has not been finalized as the transaction is still in the planning stage [2] - The company anticipates that the transaction will not lead to a change in actual control and will not constitute a restructuring listing [2] Group 2: Regulatory and Market Impact - A transaction intention agreement has been signed by all parties involved, leading to a suspension of Sunflower's stock trading starting September 8 [5] - The company is expected to disclose the transaction plan within 10 trading days, by September 22, or the stock will resume trading and the planning will be terminated [5] Group 3: Industry Context - The announcement comes amid a wave of merger and acquisition activities, with over ten A-share listed companies, including Sunflower, disclosing their restructuring progress recently [8]